IMMUNOCORE HOLDINGS PLC-ADR(NASDAQ:IMCR) stock News

IMCR Latest News, Press Relases and Analysis

All

Press Releases

a month ago - By: Resolution Therapeutics - Mentions: ALXN

Resolution Therapeutics appoints Lucy Singah as Chief Financial Officer and Daniel Kennedy as Chief Business Officer

a month ago - By: Immunocore Holdings plc

Immunocore to present at upcoming investor conferences

2 months ago - By: Zacks Investment Research - Mentions: CRMD IOVA GMAB

IOVA Q2 Earnings Miss, Stock Down on EMA Filing Withdrawal for Amtagvi

2 months ago - By: Zacks Investment Research - Mentions: LLY NKTR CRMD

Nektar Q2 Loss Narrower Than Expected, Revenues Fall Y/Y

2 months ago - By: Benzinga - Mentions: GSAT PGY ADV REAL ...

Earnings Scheduled For August 7, 2025

2 months ago - By: Zacks Investment Research - Mentions: REGN CRMD NTLA

Intellia Q2 Loss Narrower Than Expected, Pipeline Progress in Focus

2 months ago - By: Zacks Investment Research - Mentions: PBYI CRMD EXAS

PBYI's Q2 Earnings Beat Estimates, Nerlynx Sales Drive Revenues

2 months ago - By: The Motley Fool

Immunocore (IMCR) Q2 Revenue Jumps 30%

2 months ago - By: Zacks Investment Research - Mentions: CRMD VTRS

Viatris Stock Rises as Q2 Earnings & Revenues Beat Estimates

2 months ago - By: Zacks Investment Research - Mentions: CPRX CRMD ARVN

Catalyst Pharmaceuticals Q2 Earnings Beat, Firdapse Revenues Rise Y/Y

2 months ago - By: Zacks Investment Research - Mentions: CRMD ACAD ARVN

Acadia Q2 Earnings Beat, Nuplazid & Daybue Sales Drive Revenue Growth

2 months ago - By: Zacks Investment Research

Compared to Estimates, Immunocore (IMCR) Q2 Earnings: A Look at Key Metrics

2 months ago - By: Zacks Investment Research - Mentions: CRMD ADMA

ADMA Beats on Q2 Earnings and Revenues, Asceniv Drives Momentum

2 months ago - By: Immunocore Holdings plc

Immunocore reports second quarter financial results and provides a business update

2 months ago - By: Immunocore Holdings plc

Immunocore reports second quarter financial results and provides a business update

2 months ago - By: Zacks Investment Research - Mentions: NVO LLY ARVN

Novo Nordisk Q2 Earnings Beat, Sales Miss, GLP-1 Drugs Face US Hurdles

2 months ago - By: Zacks Investment Research - Mentions: JNJ HALO

HALO Stock Up on Q2 Earnings and Revenue Beat, Raised 2025 View

2 months ago - By: Zacks Investment Research - Mentions: BEAM CRMD ARVN

BEAM's Q2 Loss Narrower Than Expected, Revenues Miss Mark

2 months ago - By: Zacks Investment Research - Mentions: CRMD ARVN RXRX

RXRX Q2 Loss Wider Than Expected, Revenues Rise Y/Y, Stock Down

2 months ago - By: Zacks Investment Research - Mentions: REGN RARE ARVN

Ultragenyx's Q2 Loss Narrower Than Expected, Revenues Rise Y/Y

2 months ago - By: Zacks Investment Research - Mentions: CRMD ESPR ARVN

ESPR's Q2 Earnings & Revenues Trump Estimates, Stock Rises

2 months ago - By: Zacks Investment Research - Mentions: PRGO CRMD GMAB

Perrigo Beats on Q2 Earnings & Sales, Stock Down on '25 Sales View Cut

2 months ago - By: Zacks Investment Research - Mentions: JAZZ CRMD GMAB

JAZZ Stock Down on Wider-Than-Expected Q2 Loss, '25 Sales View Cut

2 months ago - By: Zacks Investment Research - Mentions: ZTS CRMD ARVN

ZTS Q2 Earnings & Revenues Beat Estimates, '25 Outlook Raised

2 months ago - By: Zacks Investment Research - Mentions: TGTX CRMD ARVN

TGTX Down as Q2 Earnings Miss Mark, Briumvi Sales Drive Top Line

2 months ago - By: Zacks Investment Research - Mentions: SIRI VRTX CRSP GMAB

CRSP Stock Down on Huge Q2 Loss, Focus on Increasing Casgevy Adoption

2 months ago - By: Zacks Investment Research - Mentions: JAZZ CRMD AXSM

AXSM Q2 Loss Narrower Than Expected, Auvelity Drives Revenues Y/Y

2 months ago - By: Zacks Investment Research - Mentions: VRTX CRMD CRSP

VRTX Q2 Earnings Beat, Stock Down as Pain Drug Misses Study Goal

2 months ago - By: Zacks Investment Research - Mentions: SNY BMRN GMAB

BioMarin Beats on Q2 Earnings & Sales, Stock Gains on Raised '25 View

2 months ago - By: Zacks Investment Research - Mentions: CRMD KRYS

KRYS Q2 Earnings and Sales Top Estimates, Stock Down on Q3 Outlook

3 months ago - By: Zacks Investment Research - Mentions: CORT CRMD

CORT's Q2 Earnings Top Mark, Revenues Lag, '25 View Cut, Stock Down

3 months ago - By: Zacks Investment Research - Mentions: FOLD CRMD ARVN

FOLD Q2 Earnings Miss Mark, Revenues Beat on Higher Product Sales

3 months ago - By: Immunocore Holdings plc

Immunocore to report second quarter 2025 financial results and host call on August 7, 2025

3 months ago - By: Immunocore Holdings plc

Immunocore to report second quarter 2025 financial results and host call on August 7, 2025

4 months ago - By: Zacks Investment Research - Mentions: BMY BNTX CVAC

IMMUNOCORE HOLDINGS PLC-ADR (IMCR) Stock News

IMCR Latest News, Press Relases and Analysis

Resolution Therapeutics appoints Lucy Singah as Chief Financial Officer and Daniel Kennedy as Chief Business Officer

Immunocore to present at upcoming investor conferences

IOVA Q2 Earnings Miss, Stock Down on EMA Filing Withdrawal for Amtagvi

Nektar Q2 Loss Narrower Than Expected, Revenues Fall Y/Y

Earnings Scheduled For August 7, 2025

Intellia Q2 Loss Narrower Than Expected, Pipeline Progress in Focus

PBYI's Q2 Earnings Beat Estimates, Nerlynx Sales Drive Revenues

Immunocore (IMCR) Q2 Revenue Jumps 30%

Viatris Stock Rises as Q2 Earnings & Revenues Beat Estimates

Catalyst Pharmaceuticals Q2 Earnings Beat, Firdapse Revenues Rise Y/Y

Acadia Q2 Earnings Beat, Nuplazid & Daybue Sales Drive Revenue Growth

Compared to Estimates, Immunocore (IMCR) Q2 Earnings: A Look at Key Metrics

ADMA Beats on Q2 Earnings and Revenues, Asceniv Drives Momentum

Immunocore reports second quarter financial results and provides a business update

Immunocore reports second quarter financial results and provides a business update

Novo Nordisk Q2 Earnings Beat, Sales Miss, GLP-1 Drugs Face US Hurdles

HALO Stock Up on Q2 Earnings and Revenue Beat, Raised 2025 View

BEAM's Q2 Loss Narrower Than Expected, Revenues Miss Mark

RXRX Q2 Loss Wider Than Expected, Revenues Rise Y/Y, Stock Down

Ultragenyx's Q2 Loss Narrower Than Expected, Revenues Rise Y/Y

ESPR's Q2 Earnings & Revenues Trump Estimates, Stock Rises

Perrigo Beats on Q2 Earnings & Sales, Stock Down on '25 Sales View Cut

JAZZ Stock Down on Wider-Than-Expected Q2 Loss, '25 Sales View Cut

ZTS Q2 Earnings & Revenues Beat Estimates, '25 Outlook Raised

TGTX Down as Q2 Earnings Miss Mark, Briumvi Sales Drive Top Line

CRSP Stock Down on Huge Q2 Loss, Focus on Increasing Casgevy Adoption

AXSM Q2 Loss Narrower Than Expected, Auvelity Drives Revenues Y/Y

VRTX Q2 Earnings Beat, Stock Down as Pain Drug Misses Study Goal

BioMarin Beats on Q2 Earnings & Sales, Stock Gains on Raised '25 View

KRYS Q2 Earnings and Sales Top Estimates, Stock Down on Q3 Outlook

CORT's Q2 Earnings Top Mark, Revenues Lag, '25 View Cut, Stock Down

FOLD Q2 Earnings Miss Mark, Revenues Beat on Higher Product Sales

Immunocore to report second quarter 2025 financial results and host call on August 7, 2025

Immunocore to report second quarter 2025 financial results and host call on August 7, 2025

CureVac Soars 41% in a Month on a $1.25B Buyout Offer From BioNTech